KRAS and cancer: Given that the phosphorylation cascade dominates KRAS-induced downstream signaling, obtaining a comprehensive profile of the proteome and phosphoproteome will be particularly informative to improve our understanding of the phenotypic heterogeneity of KRAS-mutant cancers 19, 20.